Fernanda M.F. Roleira

Prof. Dr. Fernanda M.F. Roleira

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2005 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Fernanda BorgesFernanda Borges
Fernanda Borges
FRFernanda M.F. Roleira
Fernanda M.F. Roleira
NMN. Milhazes
N. Milhazes
LSLourdes Santana
Lourdes Santana
EUEugenio Uriarte
Eugenio Uriarte
Coumarins, also known as benzopyrones, are present in remarkable amounts in plants, although their presence has also been detected in microorganisms and animal sources. The structural diversity found in this family of compounds led to the division into different categories, from simple coumarins to many other kinds of policyclic coumarins, such as furocoumarins and pyranocoumarins. Simple coumarins and analogues are a large class of compounds that have attracted their interest for a long time due to their biological activities: they have shown to be useful as antitumoural, anti-HIV agents and as CNSactive compounds. Furthermore, they have been reported to have multiple biological activities (anticoagulant, anti-inflammatory), although all these properties have not been evaluated systematically. In addition, their enzyme inhibition properties, antimicrobial and antioxidant activities are other foremost topics of this field of research. The present work is to survey the information published or abstracted from 1990 till 2003, which is mainly related to the occurrence, synthesis and biological importance of simple coumarins and some analogues, such as biscoumarins and triscoumarins. Data are also highlighted, concerning the development of new synthetic strategies that could help in drug design and in the work on SAR or QSAR.

1 September 2015 in Food Chemistry
Verified
Journal Article
Closed access
FRFernanda M.F. Roleira
Fernanda M.F. Roleira
ESElisiário Tavares da Silva
Elisiário Tavares da Silva
CVCarla Varela
Carla Varela
SCSaul C. Costa
Saul C. Costa
TSTiago Silva
Tiago Silva
Fernanda BorgesFernanda Borges
Fernanda Borges

1 January 2002 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Fernanda BorgesFernanda Borges
Fernanda Borges
Eduarda FernandesEduarda Fernandes
Eduarda Fernandes
FRFernanda M.F. Roleira
Fernanda M.F. Roleira
Xanthine oxidase (XO) is a highly versatile flavoprotein enzyme, ubiquitous among species (from bacteria to human) and within the various tissues of mammals. The enzyme catalyses the oxidative hydroxylation of purine substrates at the molybdenum centre (the reductive half-reaction) and subsequent reduction of O2 at the flavin centre with generation of reactive oxygen species (ROS), either superoxide anion radical or hydrogen peroxide (the oxidative half-reaction). Many diseases, or at least symptoms of diseases, arise from a deficiency or excess of a specific metabolite in the body. For an example of an excess of a particular metabolite that produces a disease state is the excess of uric acid which can led to gout. Inhibition of XO decreases the uric acid levels, and results in an antihyperuricemic effect. Allopurinol, first synthesised as a potential anticancer agent, is nowadays a clinically useful xanthine oxidase inhibitor used in the treatment of gout. There is overwhelming acceptance that xanthine oxidase serum levels are significantly increased in various pathological states like hepatitis, inflammation, ischemia-reperfusion, carcinogenesis and aging and that ROS generated in the enzymatic process are involved in oxidative damage. Thus, it may be possible that the inhibition of this enzymatic pathway would be beneficial. In this review the State of the Art will be presented, which includes a summary of the progress made over the past years in the knowledge of the structure and mechanism of the enzyme, associated pathological states, and in the efforts made towards the development of new xanthine oxidase inhibitors.

1 December 2004 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
LSLourdes Santana
Lourdes Santana
EUEugenio Uriarte
Eugenio Uriarte
FRFernanda M.F. Roleira
Fernanda M.F. Roleira
NMN. Milhazes
N. Milhazes
Fernanda BorgesFernanda Borges
Fernanda Borges
The scope of this review encompasses the importance of furocoumarins and the most important developments in this field that have been made in recent years, with particular emphasis placed on the aspects related to medicinal chemistry. A concise and exhaustive overview is given regarding the methods used for the synthesis of these compounds, new furocoumarins isolated from natural sources, and the most significant biological properties associated with these molecules. The section describing the synthetic methods is organized on the basis of the key step used for the formation of the two different oxygenated rings. In this respect there are three possibilities: (i) formation of the furan ring onto the coumarin, (ii) formation of the pyrone ring onto the benzofuran and (iii) the simultaneous formation of both oxygenated rings onto a benzene unit. The most recent preparative approaches are discussed along with modifications or improvements to methods that, though not particularly new, are still commonly used. The recently discovered natural furocoumarins are focused and presented in tables that provide information about its structure and source. The discussion of the biological importance of furocoumarins mainly focuses on their more relevant applications in photochemotherapy, but also provides examples of their versatility in a range of applications in the fields of biology and pharmacology.

19 April 2011 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
TSTeresa L. Serafim
Teresa L. Serafim
FCFilipa Carvalho
Filipa Carvalho
M. P. M. MarquesM. P. M. Marques
M. P. M. Marques
RCRita Calheiros
Rita Calheiros
TSTiago Silva
Tiago Silva
POPaulo Oliveira
Paulo Oliveira

1 August 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
FRFernanda M.F. Roleira
Fernanda M.F. Roleira
CSChristophe Siquet
Christophe Siquet
EOElizabeta Orrù
Elizabeta Orrù
EGE. Manuela Garrido
E. Manuela Garrido
JGJorge Garrido
Jorge Garrido
Fernanda BorgesFernanda Borges
Fernanda Borges